The GZMB gene helps certain immune cells make granzyme B, a protein they use to destroy virus infected cells, some cancer cells, and other abnormal cells. This gene helps your body clear threats in a controlled way. If the GZMB gene does not work properly, immune defense may be less effective and inflammation may be harder to regulate. Some variants in the GZMB gene have been linked to differences in infection, autoimmunity, and cancer risk.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, which are the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
GZMBGene function
What if the gene works
The GZMB gene helps certain immune cells remove cells infected by viruses, damaged cells, and some cancer cells by triggering controlled cell death. This supports the body’s defense against infection and helps keep tissues healthy.
Risk
What if the gene does not work
If the GZMB gene works less well, immune cells may release less granzyme B, making cell killing less effective. Milder variants may partly reduce this effect, while more severe variants can impair it further.
Treatment
What does that mean for your treatment
No GZMB-specific treatment or management approach is currently established for people with a pathogenic variant in the GZMB gene. Granzyme B is being studied as a biomarker of immune activity and treatment response, especially in cancer immunotherapy and inflammatory conditions, but this has not yet led to guideline-based drug choices.
Gene function
What if the gene works
Your immune system depends on the GZMB gene for precise, controlled defense. It is especially active in natural killer cells and killer T cells, which are the immune cells that remove infected or abnormal cells. Understanding how the GZMB gene helps immune cells kill infected cells makes it easier to see how your body clears threats while limiting damage to nearby healthy tissue.
The GZMB gene helps certain immune cells attack cells that are infected by viruses or have become abnormal. Its protein is stored in tiny packets and released only when these immune cells recognize a clear target.
Granzyme B starts programmed cell death, which is your body’s orderly way of removing cells that should no longer stay. This allows worn out, infected, or harmful cells to be cleared in a controlled way.
The GZMB gene works alongside perforin, a partner protein that helps granzyme B enter the target cell. Once inside, granzyme B cuts key proteins so the cell shuts itself down in an organized manner.
This gene supports everyday immune surveillance, meaning the routine checking your immune system does to spot problem cells early. That process helps the body respond to infected cells and some emerging cancer cells.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can affect how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GZMB gene can change how much granzyme B a cell makes or how well the protein folds, is stored, and cuts its target proteins. This overview of how GZMB gene variants affect protein function reflects a spectrum: some changes are mild and only slightly reduce activity, while more disruptive variants can lower stability, block activation, or weaken binding to target molecules. Variants outside the coding region may also change gene expression rather than the protein itself.
How variants are linked to conditions
Current evidence on how variants of the GZMB gene are linked to conditions is still developing. The GZMB gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. Anyone with a confirmed GZMB-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the GZMB gene. GZMB may play a part in how the immune system responds, but overall risk is usually shaped by many genes along with everyday factors such as age, infections, smoking, and general health.
Inheritance of GZMB variants
There is not yet a broadly confirmed Mendelian pattern for inheritance of the GZMB gene variants tied to a specific human condition, and this picture may become clearer as research develops. In practical terms, inheritance of the GZMB gene variants is not currently described in the same established way as well-known autosomal dominant or autosomal recessive conditions. The GZMB gene is located on chromosome 14, which is an autosome, so you inherit one copy from each parent.
What does my GZMB result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for the GZMB gene, though this understanding can change as research develops. If you have a specific GZMB result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the GZMB gene usually uses a blood or saliva sample. In genetic testing for GZMB variants, a lab reads the DNA sequence and compares it with the usual sequence to look for changes. Results may report a benign variant, a variant of uncertain significance, or a variant linked to disease.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the GZMB gene in routine care. Testing decisions are usually based on symptoms, personal health history, and family history, ideally with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although how much it reveals depends on the condition and the specific type of variant involved. Over time, how the body works is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or handle a drug differently, so the same treatment may work better for one person, less well for another, or cause more side effects. These differences are common and can influence how strongly a medicine works, how long it stays in the body, and how sensitive someone may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. If you want to learn more about this topic, you can explore it further in the LearnHub.
Drugs influenced by the GZMB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. For questions about side effects, new symptoms, or whether a treatment is right for you, talk with your doctor or pharmacist.
History
Researchers identified the GZMB gene during work in the 1980s on how the immune system’s killer cells attack infected or abnormal cells. Early studies of granzyme proteins helped explain that these cells do not rely on contact alone, but also release specialized enzymes to damage their targets. Building on this early work, scientists linked the GZMB gene to granzyme B, which became an important model for studying immune cell driven cell death. As immunology advanced through the 1990s and 2000s, GZMB was used widely in laboratory research to track cytotoxic T cells and natural killer cells. These historical steps shaped today’s understanding of how immune cells carry out controlled attacks during infection, inflammation, and cancer research.